Journal of Pediatrics Review

Published by: Shiraz University of Medical Sciences

A Review of Neurobehavioral Challenges in Children Exposed Prenatally to Intrauterine Opioid

Kamaledin Alaedini 1 , Kaveh Haddadi 2 , * and Leila Asadian 3
Authors Information
1 Addiction Studies PhD Candidate, School of Advanced Medical Technologies, Tehran University of Medical Sciences, Tehran, IR Iran
2 Department of Neurosurgery, Emam Khomeini Hospital, Orthopedic Research Center, Mazandaran University of Medical Sciences, Sari, IR Iran
3 Orthopedic Research Center, Mazandaran University of Medical Sciences, Sari, IR Iran
Article information
  • Journal of Pediatrics Review: July 2017, 5 (2); e9234
  • Published Online: March 12, 2017
  • Article Type: Review Article
  • Received: October 2, 2016
  • Revised: February 1, 2017
  • Accepted: February 8, 2017
  • DOI: 10.5812/jpr.9234

To Cite: Alaedini K, Haddadi K, Asadian L. A Review of Neurobehavioral Challenges in Children Exposed Prenatally to Intrauterine Opioid, J Pediatr Rev. 2017 ;5(2):e9234. doi: 10.5812/jpr.9234.

Copyright © 2017, Journal of Pediatrics Review. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
  • 1. Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician. 2010; 13(5): 401-35[PubMed]
  • 2. Heroin addiction. 2013;
  • 3. Merry J. A social history of heroin addiction. Br J Addict Alcohol Other Drugs. 1975; 70(3): 307-10[PubMed]
  • 4. Courtwright D. Dark Paradise: Opiate Addiction in America before 1940. 1982;
  • 5. Menninger-Lerchenthal E. Die morphin kranheit der neugeborenen morphine stischer mutter Monatsschr. F Kinderh. 1934; 60: 182-93
  • 6. Goodfriend MJ, Shey IA, Klein MD. The effects of maternal narcotic addiction on the newborn. Am J Obstet Gynecol. 1956; 71(1): 29-36[PubMed]
  • 7. Cobrinik RW, Hood RJ, Chusid E. The effect of maternal narcotic addiction on the newborn infant; review of literature and report of 22 cases. Pediatrics. 1959; 24(2): 288-304[PubMed]
  • 8. Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. JAMA. 1998; 280(22): 1936-43[PubMed]
  • 9. Reddy AM, Harper RG, Stern G. Observations on heroin and methadone withdrawal in the newborn. Pediatrics. 1971; 48(3): 353-8[PubMed]
  • 10. Auriacombe M, Fatseas M, Dubernet J, Daulouede JP, Tignol J. French field experience with buprenorphine. Am J Addict. 2004; 13 Suppl 1-28[DOI][PubMed]
  • 11. Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Treatment Improvement Protocol (TIP) series 40. 2004;
  • 12. Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA. 2012; 307(18): 1934-40[DOI][PubMed]
  • 13. Haddadi K. Outlines and outcomes of instrumented posterior fusion in the pediatric cervical spine: a review article. J Pediatr Rev. 2016; 4(1)
  • 14. Haddadi K. Pediatric lumbar disc herniation: a review of manifestations, diagnosis and management. J Pediatr Rev. 2016; 4(1)
  • 15. Haddadi K. Pediatric Endoscopic Third Ventriculostomy: A Narrative Review of Current Indications, Techniques and Complications. J Pediatr Rev. 2016; 4(2)
  • 16. Carrieri MP, Amass L, Lucas GM, Vlahov D, Wodak A, Woody GE. Buprenorphine use: the international experience. Clin Infect Dis. 2006; 43 Suppl 4-215[DOI][PubMed]
  • 17. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CJ. Teratology and medications that affect the fetus. Williams Obstetrics. 2010; : 328
  • 18. Kaltenbach K, Berghella V, Finnegan L. Opioid dependence during pregnancy. Effects and management. Obstet Gynecol Clin North Am. 1998; 25(1): 139-51[PubMed]
  • 19. Riksheim M, Gossop M, Clausen T. From methadone to buprenorphine: changes during a 10 year period within a national opioid maintenance treatment programme. J Subst Abuse Treat. 2014; 46(3): 291-4[DOI][PubMed]
  • 20. Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010; 363(24): 2320-31[DOI][PubMed]
  • 21. Minozzi S, Amato L, Bellisario C, Ferri M, Davoli M. Maintenance agonist treatments for opiate-dependent pregnant women. Cochrane Database Syst Rev. 2013; (12)[DOI][PubMed]
  • 22. Buchi KF, Suarez C, Varner MW. The prevalence of prenatal opioid and other drug use in Utah. Am J Perinatol. 2013; 30(3): 241-4[DOI][PubMed]
  • 23. Drug Misuse: Psychosocial Interventions. 2007;
  • 24. Keegan J, Parva M, Finnegan M, Gerson A, Belden M. Addiction in pregnancy. J Addict Dis. 2010; 29(2): 175-91[DOI][PubMed]
  • 25. Drug misuse statistics in Scotland. 2011;
  • 26. Flak AL, Su S, Bertrand J, Denny CH, Kesmodel US, Cogswell ME. The association of mild, moderate, and binge prenatal alcohol exposure and child neuropsychological outcomes: a meta-analysis. Alcohol Clin Exp Res. 2014; 38(1): 214-26[DOI][PubMed]
  • 27. Bauer CR, Shankaran S, Bada HS, Lester B, Wright LL, Krause-Steinrauf H, et al. The Maternal Lifestyle Study: drug exposure during pregnancy and short-term maternal outcomes. Am J Obstet Gynecol. 2002; 186(3): 487-95[PubMed]
  • 28. The Maternal Lifestyle Study (MLS). 2014;
  • 29. Ackerman JP, Riggins T, Black MM. A review of the effects of prenatal cocaine exposure among school-aged children. Pediatrics. 2010; 125(3): 554-65[DOI][PubMed]
  • 30. Melinder A, Konijnenberg C, Sarfi M. Deviant smooth pursuit in preschool children exposed prenatally to methadone or buprenorphine and tobacco affects integrative visuomotor capabilities. Addiction. 2013; 108(12): 2175-82[DOI][PubMed]
  • 31. Slinning K. Foster placed children prenatally exposed to poly-substances--attention-related problems at ages 2 and 4 1/2. Eur Child Adolesc Psychiatry. 2004; 13(1): 19-27[DOI][PubMed]
  • 32. Walhovd KB, Fjell AM, Espeseth T. Cognitive decline and brain pathology in aging--need for a dimensional, lifespan and systems vulnerability view. Scand J Psychol. 2014; 55(3): 244-54[DOI][PubMed]
  • 33. Hans SL. Prenatal drug exposure: behavioral functioning in late childhood and adolescence. NIDA Res Monogr. 1996; 164: 261-76[PubMed]
  • 34. Rigoli D, Piek JP, Kane R, Oosterlaan J. An examination of the relationship between motor coordination and executive functions in adolescents. Dev Med Child Neurol. 2012; 54(11): 1025-31[DOI][PubMed]
  • 35. Logan BA, Heller NA, Paul JA, Morrison DG, Brown M, Krishnan R, et al. Longitudinal Developmental Outcomes In The First Year In Opiateexposed Infants: Role Of Prenatal Alcohol Exposure. Alcohol Clin Exp Res. 2011; 35: 40A
  • 36. Sundelin Wahlsten V, Sarman I. Neurobehavioural development of preschool-age children born to addicted mothers given opiate maintenance treatment with buprenorphine during pregnancy. Acta Paediatr. 2013; 102(5): 544-9[DOI][PubMed]
  • 37. van Baar A. Development of infants of drug dependent mothers. J Child Psychol Psychiatry. 1990; 31(6): 911-20[PubMed]
  • 38. Skinner ML, Haggerty KP, Fleming CB, Catalano RF. Predicting functional resilience among young-adult children of opiate-dependent parents. J Adolesc Health. 2009; 44(3): 283-90[DOI][PubMed]
  • 39. Dorrie N, Focker M, Freunscht I, Hebebrand J. Fetal alcohol spectrum disorders. Eur Child Adolesc Psychiatry. 2014; 23(10): 863-75[DOI][PubMed]
  • 40. Tamnes CK, Ostby Y, Walhovd KB, Westlye LT, Due-Tonnessen P, Fjell AM. Neuroanatomical correlates of executive functions in children and adolescents: a magnetic resonance imaging (MRI) study of cortical thickness. Neuropsychologia. 2010; 48(9): 2496-508[DOI][PubMed]
  • 41. Sanchez ES, Bigbee JW, Fobbs W, Robinson SE, Sato-Bigbee C. Opioid addiction and pregnancy: perinatal exposure to buprenorphine affects myelination in the developing brain. Glia. 2008; 56(9): 1017-27[DOI][PubMed]
  • 42. Konijnenberg C, Melinder A. Prenatal exposure to methadone and buprenorphine: a review of the potential effects on cognitive development. Child Neuropsychol. 2011; 17(5): 495-519[DOI][PubMed]
  • 43. Creanga AA, Sabel JC, Ko JY, Wasserman CR, Shapiro-Mendoza CK, Taylor P, et al. Maternal drug use and its effect on neonates: a population-based study in Washington State. Obstet Gynecol. 2012; 119(5): 924-33[DOI][PubMed]
  • 44. Mactier H, Shipton D, Dryden C, Tappin DM. Reduced fetal growth in methadone-maintained pregnancies is not fully explained by smoking or socio-economic deprivation. Addiction. 2014; 109(3): 482-8[DOI][PubMed]
  • 45. Leitner Y, Fattal-Valevski A, Geva R, Bassan H, Posner E, Kutai M, et al. Six-year follow-up of children with intrauterine growth retardation: long-term, prospective study. J Child Neurol. 2000; 15(12): 781-6[DOI][PubMed]
  • 46. Monk C, Spicer J, Champagne FA. Linking prenatal maternal adversity to developmental outcomes in infants: the role of epigenetic pathways. Dev Psychopathol. 2012; 24(4): 1361-76[DOI][PubMed]
  • 47. Streissguth AP, Bookstein FL, Barr HM, Sampson PD, O'Malley K, Young JK. Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects. J Dev Behav Pediatr. 2004; 25(4): 228-38[PubMed]
  • 48. Lester BM, Lagasse LL. Children of addicted women. J Addict Dis. 2010; 29(2): 259-76[DOI][PubMed]
  • 49. Walhovd KB, Watts R, Amlien I, Woodward LJ. Neural tract development of infants born to methadone-maintained mothers. Pediatr Neurol. 2012; 47(1): 1-6[DOI][PubMed]
  • 50. Walhovd KB, Westlye LT, Moe V, Slinning K, Due-Tonnessen P, Bjornerud A, et al. White matter characteristics and cognition in prenatally opiate- and polysubstance-exposed children: a diffusion tensor imaging study. AJNR Am J Neuroradiol. 2010; 31(5): 894-900[DOI][PubMed]
  • 51. Wang Y, Han TZ. Prenatal exposure to heroin in mice elicits memory deficits that can be attributed to neuronal apoptosis. Neuroscience. 2009; 160(2): 330-8[DOI][PubMed]
  • 52. Lewis M, Kestler L. Gender differences in prenatal substance exposure. 2012;
  • 53. Weinberg MK, Tronick EZ, Cohn JF, Olson KL. Gender differences in emotional expressivity and self-regulation during early infancy. Dev Psychol. 1999; 35(1): 175-88[PubMed]
  • 54. Delaney-Black V, Covington C, Nordstrom B, Ager J, Janisse J, Hannigan JH, et al. Prenatal cocaine: quantity of exposure and gender moderation. J Dev Behav Pediatr. 2004; 25(4): 254-63[PubMed]
  • 55. Sameroff A. A unified theory of development: a dialectic integration of nature and nurture. Child Dev. 2010; 81(1): 6-22[DOI][PubMed]
  • 56. Yumoto C, Jacobson SW, Jacobson JL. Fetal substance exposure and cumulative environmental risk in an African American cohort. Child Dev. 2008; 79(6): 1761-76[DOI][PubMed]
  • 57. Minnes S, Singer LT, Kirchner HL, Short E, Lewis B, Satayathum S, et al. The effects of prenatal cocaine exposure on problem behavior in children 4-10 years. Neurotoxicol Teratol. 2010; 32(4): 443-51[DOI][PubMed]
  • 58. Muhuri PK, Gfroerer JC. Substance use among women: associations with pregnancy, parenting, and race/ethnicity. Matern Child Health J. 2009; 13(3): 376-85[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments